(VIANEWS) – RYANAIR HOLD. PLC (RYA.IR), J.MARTINS,SGPS (JMT.LS), VOSS VEKSEL OGLAND (VVL.OL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. RYANAIR HOLD. PLC (RYA.IR)
38.7% sales growth and 23.1% return on equity
Ryanair Holdings plc, together with its subsidiaries, provides scheduled-passenger airline services in Ireland, the United Kingdom, Spain, Italy, and internationally. The company is also involved in the provision of various ancillary services, such as non-flight scheduled and Internet-related services, as well as in-flight sale of beverages, food, duty-free, and merchandise; and markets car hire, travel insurance, and accommodation services through its website and mobile app. Furter, it offers aircraft and passenger handling, ticketing, and maintenance and repair services; and markets car parking, fast-track, airport transfers, attractions, and activities on its website and mobile app, as well as sells gift vouchers. The company was incorporated in 1996 and is headquartered in Swords, Ireland.
Earnings Per Share
As for profitability, RYANAIR HOLD. PLC has a trailing twelve months EPS of €1.41.
PE Ratio
RYANAIR HOLD. PLC has a trailing twelve months price to earnings ratio of 12.19. Meaning, the purchaser of the share is investing €12.19 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.1%.
Yearly Top and Bottom Value
RYANAIR HOLD. PLC’s stock is valued at €17.18 at 02:20 EST, way below its 52-week high of €21.73 and way higher than its 52-week low of €13.41.
Volume
Today’s last reported volume for RYANAIR HOLD. PLC is 970463 which is 63.45% below its average volume of 2655850.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 150% and a drop 144.4% for the next.
More news about RYANAIR HOLD. PLC.
2. J.MARTINS,SGPS (JMT.LS)
17.7% sales growth and 28.68% return on equity
Jerónimo Martins, SGPS, S.A. operates in the food distribution and specialized retail sectors in Portugal, Poland, and Colombia. The company operates through Portugal Retail; Portugal Cash & Carry; Poland Retail; Colombia Retail; and Others, Eliminations and Adjustments segments. It operates food stores under the Biedronka name; and a chain of health and beauty stores under the Hebe banner in Poland, as well as food stores under the Ara name in Colombia. The company also operates supermarkets under the Pingo Doce banner; and cash and carry stores under the Recheio name in Portugal, and under the Bodega del Canasto name in Colombia. In addition, it operates restaurants under the Pingo Doce name; para-pharmacies and petrol stations under Bem-Estar brand; and clothing under Code brand. Further, the company operates coffee shops and kiosks under the Jeronymo name; and chocolates and confectionary retail stores under Hussel name. Additionally, the company engages in human resources top management, real estate management and administration, training, and saline brackish waters aquaculture; wholesale of fruit and vegetables; retail management, consultancy, and logistics activities; purchase and sale of real estate; growing of crops and farming of animals; retail sale of health and beauty products; manufacture of milk and dairy products; rental of air transport equipment; and provision of business portfolio management, financial, and sea passenger water transport services. It is also involved in the trading and distribution of consumer goods; retail and wholesale of non-food products; other business support service activities; and provision of services in the area of wholesale and retail distribution. The company was founded in 1792 and is headquartered in Lisbon, Portugal. Jerónimo Martins, SGPS, S.A. operates as a subsidiary of Sociedade Francisco Manuel Dos Santos, S.G.P.S., S.A.
Earnings Per Share
As for profitability, J.MARTINS,SGPS has a trailing twelve months EPS of €1.04.
PE Ratio
J.MARTINS,SGPS has a trailing twelve months price to earnings ratio of 16.85. Meaning, the purchaser of the share is investing €16.85 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.68%.
Sales Growth
J.MARTINS,SGPS’s sales growth is 20.1% for the present quarter and 17.7% for the next.
Volume
Today’s last reported volume for J.MARTINS,SGPS is 508459 which is 45.65% below its average volume of 935631.
More news about J.MARTINS,SGPS.
3. VOSS VEKSEL OGLAND (VVL.OL)
17.5% sales growth and 10.95% return on equity
Voss Veksel- og Landmandsbank ASA provides banking products and services to private individuals and companies in Norway. The company offers saving accounts; car and other vehicle, home, small, and construction loans; overdrafts facilities; leasing services; bank guarantees; bank and payment cards; insurance products; and online and mobile banking services. The company was founded in 1843 and is based in Voss, Norway.
Earnings Per Share
As for profitability, VOSS VEKSEL OGLAND has a trailing twelve months EPS of kr38.43.
PE Ratio
VOSS VEKSEL OGLAND has a trailing twelve months price to earnings ratio of 7.65. Meaning, the purchaser of the share is investing kr7.65 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.95%.
Moving Average
VOSS VEKSEL OGLAND’s value is way above its 50-day moving average of kr254.16 and way higher than its 200-day moving average of kr230.71.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2024, the estimated forward annual dividend rate is 14.1 and the estimated forward annual dividend yield is 5.34%.
Yearly Top and Bottom Value
VOSS VEKSEL OGLAND’s stock is valued at kr294.00 at 02:20 EST, above its 52-week high of kr268.00.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 46.9% and 48.5%, respectively.
More news about VOSS VEKSEL OGLAND.
4. SANOFI (SAN.PA)
7.4% sales growth and 5.82% return on equity
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €4.3.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 21.15. Meaning, the purchaser of the share is investing €21.15 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.82%.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €90.96 at 02:20 EST, way under its 52-week high of €106.14 and way higher than its 52-week low of €80.60.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 5.2% and positive 0.8% for the next.
More news about SANOFI.
5. VERALLIA (VRLA.PA)
6% sales growth and 29.81% return on equity
Earnings Per Share
As for profitability, VERALLIA has a trailing twelve months EPS of €4.01.
PE Ratio
VERALLIA has a trailing twelve months price to earnings ratio of 8.99. Meaning, the purchaser of the share is investing €8.99 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.81%.
More news about VERALLIA.
